EDMONTON, Alberta, July 10 /PRNewswire-FirstCall/ -- Medical Services International Inc. wishes to announce that it has begun a very active marketing program for its VScan TB rapid test kit in Western countries. As part of this program, the Company is looking for a partner in the United States to begin the process of applying for regulatory approval in the United States. The Company has done significant testing of its VScan rapid test kit for TB and is confident that its test data will be acceptable. The VScan TB test kit is already approved in several Eastern Europe countries as well as Southeast Asia. Should the VScan TB test kit be approved for use in North America, the Company believes that the demand will be significant, increasing the Company’s overall financial performance.
It becomes obvious that TB is increasing in North America. Recent events that the public were made aware of was the individual flying into Montreal, Canada from Prague with active TB and an individual with active TB entering a Day Care Facility in Edmonton, Alberta on July 9, 2007 to pick up children. While the Capital Health Authority of Edmonton has indicated that exposure in this case was very low risk, it shows that Tuberculosis (TB) is in the general population and is being spread. What the Capital Health authority did not address is the exposure to the children that were being picked up. According to the World Health Organization, TB will kill over 8 million people this year. TB is the most infectious disease currently prevalent throughout the world. Current testing procedures are inaccurate and give false positives 30% of the time. The VScan TB test kit gives no false positives (100% Specificity) and during independent testing has shown an accuracy of over 85%. There is no other test that is as accurate as the VScan TB test kit. The key to controlling the spread of Tuberculosis is rapid, accurate testing so that treatment can begin immediately. TB is transmitted through the droplets that result from an individual coughing.
About VScan
The VScan rapid test kit is a single use, easy to use, accurate test for the screening of HIV 1&2, Hepatitis B&C, Malaria, Dengue Fever, West Nile, Syphilis, and Prostate Cancer. The kits cannot be sold in Canada.
Medical Services International Inc. trades in the United States on the NQB Pink Sheets under the symbol “MSITF”. For further information, please contact Robert Talbot at (780) 430 6363 or http://www.medicalservicesintl.com or http://www.minerva-biotech.com
NOTE: Certain statements in this press release are “forward-looking statements” within the meaning Private Securities Act of 1885. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filings with regulatory bodies.
Medical Services International Inc.
CONTACT: Robert Talbot of Medical Services International Inc.,+1-780-430-6363
